Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Cellino logo — Awaken your best stem cells—through machines.

Cellino

Awaken your best stem cells—through machines.

Founded 2017 United States Cambridge, United States 107 employees Series A Total: $121.01M Biotechnology, Design

General Information

Company Name Cellino
Founded Year 2017
Location United States Cambridge, United States +1
Founders / Decision Makers
Team member
Employees 107
Industries Biotechnology, Design
Funding Stage Series A
Social

Get notified when Cellino moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Cellino

Cellino, founded in 2017, is pioneering in the fields of Biotechnology and Design from its base in the United States. With a bold slogan, "Awaken your best stem cells—through machines," Cellino aims to revolutionize health by introducing a scalable biomanufacturing technology for personalized cell, tissue, and organ replacement therapies. Their mission is to increase healthspan for billions globally, spanning generations.

Recently, Cellino secured a $25.00M grant investment on 01 September 2024, funded by the US Department of Health and Human Services. This noteworthy investment underscores the company's potential and the confidence shown by esteemed investors in its innovative approach to transformative medicine. For venture capitalists, Cellino presents a compelling opportunity to invest in a visionary entity at the forefront of health innovation.

Taxonomy: biomanufacturing technology, personalized cell therapies, iPSC-derived treatments, regenerative medicine, chronic degenerative diseases, automated biomanufacturing, healthspan enhancement, vision loss therapy, Parkinson's disease therapy, cell replacement therapies, tissue engineering, organ replacement therapies, stem cell therapy, machine-enabled medicine, scalable biotech solutions

Services & Products

Personalized regenerative medicine
AI-driven optical bioprocessing
Patient-specific biomanufacturing
Scalable bioprocess solutions

Target Customers

Patients with degenerative diseases Healthcare facilities Biotech and pharmaceutical companies

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 1 •••• •••• 01 Sep 2024
Series A •••••• 5
Investor Investor Investor Investor Investor
01 Jan 2022
Seed •••••• 4
Investor Investor Investor Investor
01 Feb 2021
Seed •••••• 1
Investor
01 Mar 2019
Grant •••••• 1
Investor
01 Nov 2017

View All 6 Funding Rounds

Latest News

View All
Alumni startup secures 16M in funding — Seas.harvard.edu
Alumni startup secures 16M in funding
Seas.harvard.edu Feb 03, 2021

Cellino Alternatives & Competitors

View All Alternatives
Cellino vs
Cellino
Cellino

Machines that reawaken your best stem cells.

Cellino vs
Orca Bio
Orca Bio United States

Transforming allogeneic cell therapy for patients with cancer and autoimmune diseases.

Series D
327 employees
Health Care, Pharmaceutical
Compare Cellino vs Orca Bio
Cellino vs
Aspen Neuroscience, Inc.
Aspen Neuroscience, Inc. United States

Developing autologous iPSC-derived cell replacement therapies for Parkinson’s disease and other CNS...

Series C
128 employees
Biotechnology, Health and Wellness
Compare Cellino vs Aspen Neuroscience, Inc.
Also compare with: Cellino vs X-Therma Inc. X-Therma Inc. View all alternatives

FAQ About Cellino

Awaken your best stem cells—through machines.
Cellino was founded in 2017.
Cellino is headquartered in Cambridge, United States.
Cellino operates in the following industries: Biotechnology, Design.
Cellino has approximately 107 employees.
Cellino has completed 6 funding rounds, raising a total of $121.01M. The latest funding stage is Series A.
Cellino offers: Personalized regenerative medicine, AI-driven optical bioprocessing, Patient-specific biomanufacturing, Scalable bioprocess solutions.
Top alternatives and competitors to Cellino include Cellino, Orca Bio, Aspen Neuroscience, Inc., X-Therma Inc., ClexBio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cellino and Cellino are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Cellino and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy